1887
Volume 2011, Issue 1
  • ISSN: 2220-2730
  • E-ISSN:

There is no abstract available for this article.

Loading

Article metrics loading...

/content/journals/10.5339/ahcsps.2011.5
2011-04-14
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/ahcsps/2011/1/ahcsps.2011.5.html?itemId=/content/journals/10.5339/ahcsps.2011.5&mimeType=html&fmt=ahah

References

  1. [1]. Bonow RO, , Carabello BA, and Chatterjee K et al. ACC/AHA. 2008 focused update incorporated into the ACC/AHA 2006 Guidelinesfor the Management of Patients with Valvular Heart Disease. A report of theAmerican College of Cardiology/American Heart Association Task Force onPractice Guidelines (writing Committee to Revise the 1998 guidelines for themanagement of patients with valvular heart disease). . Circulation . 2008; ;118: : e523– e661 .
    [Google Scholar]
  2. [2]. Vahanian A, , Baumgartner H, and Bax J et al. Guidelines on the management of valvular heart disease. Task Force on theManagement of Valvular Heart Disease of the European Society of Cardiology. . EurHeart J . 2007; ;28: : 230– 268 .
    [Google Scholar]
  3. [3]. Tricoci P., , Allen KM., , Kramer JM., , Califf RM., and Smith SC Jr.. Scientific evidence underlying the ACC/AHA clinical practice guidelines. . JAMA . 2009; ;301: : 831– 841 .
    [Google Scholar]
  4. [4]. Carpetis JR., , Steer AC., , Mulholland EK., and Weber M.. The global burden of group A streptococcal diseases. . Lancet Infect Dis . 2005; ;5: : 685– 694 .
    [Google Scholar]
  5. [5]. Carpetis JR.. Rheumatic heart disease in developing countries. . N Engl J Med . 2007; ;357: : 439– 441 .
    [Google Scholar]
  6. [6]. Lopez AD., , Mathers CD., , Ezzati M., , Jamison DT., and Murray CJL. . Global Burden of Disease and Risk Factors . Oxford University Press and WorldBank; , New York: . 2006; ;
    [Google Scholar]
  7. [7]. Marijon E, , Ou P, and Celermajer DS et al. Prevalence of rheumatic heart disease detected by echocardiographic screening. . NEngl J Med . 2007; ;357: : 470– 476 .
    [Google Scholar]
  8. [9]. Supino, PG ,Borer, JS ,Yin, A ,Dillingham, EandMcClymont, W,The epidemiology of valvular heart Diseases: the problem is growing. In: Borer JSand Isom OW (eds): Pathophysiology, Evaluation and Management of Valvular HeartDiseases, Volume II. Adv Cardiol. Basel, Karger, 2004, vol 41, pp 9–15.
  9. [10]. Mensah GA.. The burden of valvular heart disease. . Otto CM and ., Bonow RO. (eds), ValvularHeart Disease: A Companion to Braunwald’s Heart Disease . 2009; ; Saunders/Elsevier; , Philadelphia: . 1– 18 .
    [Google Scholar]
  10. [11]. Lindroos M., , Kupari M., , Heikkila J., and Tilvis R.. Prevalence of aortic valve abnormalities in the elderly: an echocardiographicstudy of a random population sample. . J Am Coll Cardiol . 1993; ;21: : 1220– 1225 .
    [Google Scholar]
  11. [12]. Singh JP, , Evans JC, and Levy D et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation(the Framingham Heart Study). . Am J Cardiol . 1999; ;83: : 897– 902 .
    [Google Scholar]
  12. [13]. Nkomo VT., , Gardin JM., , Skelton TN., , Gottdiener JS., , Scott CG., and Enriquez-Sarano M.. Burden of valvular heart diseases: a population-based study. . Lancet . 2006; ;368: : 1005– 1011 .
    [Google Scholar]
  13. [14]. Grigioni F., , Enriquez-Sarano M., , Zehr KJ., , Bailey KR., and Tajik AJ. . Ischemic mitral regurgitation: long-term outcome and prognostic implications withquantitative Doppler assessment. . Circulation . 2001; ;103: : 1759– 1764 .
    [Google Scholar]
  14. [15]. Koelling TM., , Aaronson KD., , Cody RJ., and Bach MD.. Armstrong WF. Prognostic significance of mitral regurgitation and tricuspidregurgitation in patients with left ventricular systolic dysfunction. . Am Heart J . 2002; ;144: : 524– 529 .
    [Google Scholar]
  15. [16]. Robbins JD., , Maniar PB., , Cotts W., , Parker MS., , Bonow RO., and Gheorghiade M.. Prevalence and severity of mitral regurgitation in chronic systolic heart failure. . AmJ Cardiol . 2003; ;91: : 360– 362 .
    [Google Scholar]
  16. [17]. Brown JM., , O’Brien SM., , Wu C., , Sikora JH., , Griffith BP., and Gammie JS.. Isolated aortic valve replacement in North America comprising 108,687 patientsin 10 years: Changes in risks, valve types, and outcomes in the Society ofThoracic Surgeons National Database. . J Thorac Cardiovasc Surg . 2009; ;137: : 82– 90 .
    [Google Scholar]
  17. [18]. Goodney PP., , O’Connor GT., , Wennberg DE., and Birkmeyer JE. . Do hospitals with low mortality rates in coronary artery bypass also perform well invalve replacement?. . Ann Thorac Surg . 2003; ;l76: : 1131– 1137 .
    [Google Scholar]
  18. [19]. Gammie JS., , O’Brien SM., , Griffith BP., , Ferguson TB., and Peterson ED. . Influence of hospital procedural volume on care process and mortality for patientsundergoing elective surgery for mitral regurgitation. . Circulation . 2007; ;115: : 881– 886 .
    [Google Scholar]
  19. [20]. Gammie JS, , Sheng S, and Griffith BP et al. Trends in mitral valve surgery in the United States: results from the Society ofThoracic Surgeons Adult Cardiac Database. . Ann Thorac Surg . 2009; ;87: : 1431– 1439 .
    [Google Scholar]
  20. [21]. Bolling SF., , Li S., , O’Brien SM., , Brennan JM., , Prager RL., and Gammie JS.. Predictors of mitral valve repair: clinical and surgeon factors. . Ann Thorac Surg . 2010; ;90: : 1904– 1912 .
    [Google Scholar]
  21. [22]. Schelbert EB., , Vaughan-Sarrazin MS., , Welke KF., and Rosenthal GE.. Hospital volume and selection of valve type in older patients undergoing aortic valvereplacement surgery in the United States. . Circulation . 2005; ;111: : 2178– 2182 .
    [Google Scholar]
  22. [23]. Bouma BJ, , van den Brink RBA, and van der Meulen JHP et al. To operate or not on elderly patients with aortic stenosis: the decision and itsconsequences. . Heart . 1999; ;82: : 143– 148 .
    [Google Scholar]
  23. [24]. Iung B, , Cachier A, and Baron G et al. Decision-making in elderly patients with severe aortic stenosis: why are so manydenied surgery?. . Eur Heart J . 2005; ;26: : 2714– 2720 .
    [Google Scholar]
  24. [25]. Pellikka PA, , Sarano ME, and Nishimura RA et al. Outcome of 622 adults with asymptomatic, hemodynamically significantaortic stenosis during prolonged follow-up. . Circulation . 2005; ;111: : 3290– 3295 .
    [Google Scholar]
  25. [26]. Bach DS, , Siao D, and Girard SE et al. Evaluation of patients with severe symptomatic aortic stenosis who do not undergoaortic valve replacement: the potential role of subjectively overestimated operativerisk. . Circ Cardiovasc Qual Outcomes . 2009; ;2: : 533– 539 .
    [Google Scholar]
  26. [27]. Mirabel M, , Iung B, and Baron G et al. What are the characteristics of patients with severe, symptomatic, mitralregurgitation who are denied surgery?. . Eur Heart J . 2007; ;28: : 1358– 1365 .
    [Google Scholar]
  27. [28]. Toledano K., , Rudski LG., , Huynh T., , Béïque F., , Sampalis J., and Morin J.. Mitral regurgitation: determinants of referral for cardiac surgery by Canadiancardiologists. . Canad J Cardiol . 2007; ;23: : 209– 214 .
    [Google Scholar]
  28. [29]. Bach DS., , Awaia M., , Gurm HS., and Kohnstamm S.. Valvular heart disease: failure of guideline adherence for intervention inpatients with severe mitral regurgitation. . J Am Coll Cardiol . 2009; ;54: : 860– 865 .
    [Google Scholar]
  29. [30]. Tribouilloy CM, , Enriquez-Sarano M, and Schaff HV et al. Impact of preoperative symptoms on survival after surgical correction of organicmitral regurgitation: rationale for optimizing surgical indications. . Circulation . 1999; ;99: : 400– 405 .
    [Google Scholar]
  30. [31]. David TE., , Ivanov J., , Armstrong S., and Rakowski H.. Late outcomes of mitral valve repair for floppy valves: implications forasymptomatic patients. . J Thorac Cardiovasc Surg . 2003; ;125: : 1143– 1152 .
    [Google Scholar]
  31. [32]. Spertus JA, , Bonow RO, and Chan P et al. ACC/AHA 2010 methodology for the selection and creation of performancemeasures for quantifying the quality of cardiovascular care update: a report of theAmerican College of Cardiology/American Heart Association Task Force onPerformance Measures. . Circulation . 2010; ;122: : 2091– 2106 .
    [Google Scholar]
  32. [33]. Califf RM, , Peterson ED, and Gibbons RJ et al. Integrating quality into the cycle of therapeutic development. . J Am Coll Cardiol . 2002; ;40: : 1895– 1901 .
    [Google Scholar]
  33. [34]. Bridgewater B, , Hooper T, and Munsch C et al. Mitral repair best practice: proposed standards. . Heart . 2006; ;92: : 939– 944 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/ahcsps.2011.5
Loading
/content/journals/10.5339/ahcsps.2011.5
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error